FORMA Therapeutics Raises $25 Million
FORMA Therapeutics, a Cambridge, Mass.-based small molecule drug developer with an initial focus on cancer, has raised $25 million in non-dilutive Series A funding. Backers include Novartis Option Fund and Bio*One Capital.
7 January 2009•3 mins read
